Tenet Healthcare (THC) Projected to Post Earnings on Wednesday

Tenet Healthcare (NYSE:THC) will likely be announcing its Q4 2025 results before the market opens on Wednesday, February 11th. Analysts expect the company to announce earnings of $4.05 per share and revenue of $5.4680 billion for the quarter. Investors can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Wednesday, February 11, 2026 at 10:00 AM ET.

Tenet Healthcare Stock Down 4.2%

THC opened at $192.84 on Tuesday. The company’s 50-day moving average price is $198.14 and its two-hundred day moving average price is $193.40. The company has a quick ratio of 1.64, a current ratio of 1.71 and a debt-to-equity ratio of 2.27. Tenet Healthcare has a twelve month low of $109.82 and a twelve month high of $222.82. The stock has a market cap of $16.95 billion, a price-to-earnings ratio of 13.22, a PEG ratio of 0.85 and a beta of 1.45.

Insider Activity at Tenet Healthcare

In related news, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the transaction, the director owned 28,480 shares in the company, valued at $5,623,945.60. This trade represents a 7.10% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.81% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

Institutional investors have recently bought and sold shares of the stock. Boston Partners increased its stake in shares of Tenet Healthcare by 38.8% in the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after buying an additional 880,413 shares during the period. Ameriprise Financial Inc. increased its position in shares of Tenet Healthcare by 8.0% in the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after acquiring an additional 157,109 shares during the period. AQR Capital Management LLC raised its stake in shares of Tenet Healthcare by 62.3% during the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after acquiring an additional 720,160 shares during the last quarter. Bank of America Corp DE boosted its holdings in shares of Tenet Healthcare by 9.6% during the third quarter. Bank of America Corp DE now owns 1,078,585 shares of the company’s stock worth $218,996,000 after purchasing an additional 94,903 shares during the period. Finally, Alliancebernstein L.P. increased its holdings in Tenet Healthcare by 375.7% during the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock valued at $139,085,000 after purchasing an additional 624,125 shares during the period. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have issued reports on THC shares. Mizuho boosted their target price on Tenet Healthcare from $194.00 to $225.00 and gave the company an “outperform” rating in a research note on Friday, October 17th. Raymond James Financial set a $245.00 price objective on Tenet Healthcare in a research note on Wednesday, October 29th. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a research report on Wednesday, January 7th. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 31st. Finally, Truist Financial reiterated a “buy” rating and issued a $240.00 price objective (up from $225.00) on shares of Tenet Healthcare in a research note on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $233.88.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.